Predicting developmental dysplasia of the hip in at-risk newborns.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
07 Jul 2020
Historique:
received: 15 04 2020
accepted: 23 06 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 15 5 2021
Statut: epublish

Résumé

The development of developmental dysplasia of the hip can be attributed to several risk factors and often in combination with each other. When predicting the likelihood of developing this condition, clinicians tend to over and underestimate its likelihood of occurring. Therefore, the study aim is to determine among at-risk newborns how to best predict developmental dysplasia of the hip (DDH) within 8 weeks post-partum. Prospective cohort study in secondary care. Patient population included newborns at-risk for DDH - we assessed 13,276 consecutive newborns for the presence of DDH risk factors. Only newborns with at least one of the predefined risk factors and those showing an abnormal examination of the hip were enrolled (n = 2191). For the development of a risk prediction model we considered 9 candidate predictors and other variables readily available at childbirth. The main outcome measure was ultrasonography at a median age of 8 weeks using consensus diagnostic criteria; outcome assessors were blinded. The risk model includes four predictors: female sex (OR = 5.6; 95% CI: 2.9-10.9; P <  0.001); first degree family history of DDH (OR = 4.5; 95% CI: 2.3-9.0; P <  0.001), birthweight > 4000 g (OR = 1.6; 95% CI: 0.6-4.2; P = 0.34), and abnormal examination of hip (OR = 58.8; 95% CI: 31.9, 108.5; P <  0.001). This model demonstrated excellent discrimination (C statistic = 0.9) and calibration of observed and predicted risk (P = 0.35). A model without the variable 'hip examination' demonstrated similar performance. The risk model quantifies absolute risk of DDH within 8 weeks postpartum in at-risk newborns. Based on clinical variables readily available at the point of childbirth, the model will enhance parental counselling and could serve as the basis for real time decisions prior to discharge from maternity wards.

Sections du résumé

BACKGROUND BACKGROUND
The development of developmental dysplasia of the hip can be attributed to several risk factors and often in combination with each other. When predicting the likelihood of developing this condition, clinicians tend to over and underestimate its likelihood of occurring. Therefore, the study aim is to determine among at-risk newborns how to best predict developmental dysplasia of the hip (DDH) within 8 weeks post-partum.
METHODS METHODS
Prospective cohort study in secondary care. Patient population included newborns at-risk for DDH - we assessed 13,276 consecutive newborns for the presence of DDH risk factors. Only newborns with at least one of the predefined risk factors and those showing an abnormal examination of the hip were enrolled (n = 2191). For the development of a risk prediction model we considered 9 candidate predictors and other variables readily available at childbirth. The main outcome measure was ultrasonography at a median age of 8 weeks using consensus diagnostic criteria; outcome assessors were blinded.
RESULTS RESULTS
The risk model includes four predictors: female sex (OR = 5.6; 95% CI: 2.9-10.9; P <  0.001); first degree family history of DDH (OR = 4.5; 95% CI: 2.3-9.0; P <  0.001), birthweight > 4000 g (OR = 1.6; 95% CI: 0.6-4.2; P = 0.34), and abnormal examination of hip (OR = 58.8; 95% CI: 31.9, 108.5; P <  0.001). This model demonstrated excellent discrimination (C statistic = 0.9) and calibration of observed and predicted risk (P = 0.35). A model without the variable 'hip examination' demonstrated similar performance.
CONCLUSION CONCLUSIONS
The risk model quantifies absolute risk of DDH within 8 weeks postpartum in at-risk newborns. Based on clinical variables readily available at the point of childbirth, the model will enhance parental counselling and could serve as the basis for real time decisions prior to discharge from maternity wards.

Identifiants

pubmed: 32635922
doi: 10.1186/s12891-020-03454-4
pii: 10.1186/s12891-020-03454-4
pmc: PMC7341560
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

442

Subventions

Organisme : Department of Health
ID : PB-PG-0213-30046
Pays : United Kingdom

Références

Clin Orthop Relat Res. 2011 Dec;469(12):3451-61
pubmed: 21952742
Clin Orthop Relat Res. 1972 May;84:9-13
pubmed: 5032855
J Pediatr Orthop B. 1999 Apr;8(2):112-7
pubmed: 10218172
J Pediatr Orthop. 1983 Jul;3(3):354-9
pubmed: 6874934
Clin Orthop Relat Res. 1976 Sep;(119):11-22
pubmed: 954299
J Bone Joint Surg Br. 2009 May;91(5):655-8
pubmed: 19407302
Arch Dis Child. 2005 Jun;90(6):579-81
pubmed: 15908620
BMJ. 2005 Jun 18;330(7505):1413
pubmed: 15930025
J Bone Joint Surg Br. 2005 Sep;87(9):1264-6
pubmed: 16129755
Pediatrics. 1994 Jul;94(1):47-52
pubmed: 8008537
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
Lancet. 1989 Mar 18;1(8638):599-601
pubmed: 2564121
Eur J Radiol. 2012 Mar;81(3):e344-51
pubmed: 22119556
Arch Dis Child Fetal Neonatal Ed. 1997 Mar;76(2):F94-100
pubmed: 9135287
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
CMAJ. 2001 Jun 12;164(12):1669-77
pubmed: 11450209
J Pediatr Orthop B. 2002 Jul;11(3):212-8
pubmed: 12089497

Auteurs

Andreas Roposch (A)

Institute of Child Health, University College London, 30 Guildford St, London, WC1N 3EH, UK. a.roposch@ucl.ac.uk.
Department of Orthopaedic Surgery, Great Ormond Street Hospital for Children, London, UK. a.roposch@ucl.ac.uk.

Evangelia Protopapa (E)

Institute of Child Health, University College London, 30 Guildford St, London, WC1N 3EH, UK.

Olivia Malaga-Shaw (O)

Royal Free Hospital NHS Trust, London, UK.

Yael Gelfer (Y)

Department of Orthopaedic Surgery, St George's Hospital, London, UK.

Paul Humphries (P)

Department of Diagnostic Imaging, University College Hospital, London, UK.

Deborah Ridout (D)

Institute of Child Health, University College London, 30 Guildford St, London, WC1N 3EH, UK.

John H Wedge (JH)

Department of Surgery, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH